v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 151,995 $ 196,873
Accounts receivable, net of allowance of $3,282 at September 30, 2026, and $2,660 at December 31, 2025 128,724 81,514
Inventory 111,296 111,468
Supplier advances, current 339 693
Derivative assets 1,794 732
Prepaid expenses and other current assets 39,536 30,160
Total current assets 433,684 421,440
Property and equipment, net 24,441 9,298
Goodwill 110,175 7,791
Intangible assets, net 107,116 0
Supplier advances, long-term 1,593 1,860
Deferred tax assets 6,627 6,623
Right-of-use assets, net 10,337 11,592
Other assets 2,169 2,714
Total assets 696,142 461,318
Current liabilities:    
Accounts payable 46,389 25,464
Accrued expenses and other current liabilities 126,632 89,461
Derivative liabilities 2,059 1,507
Total current liabilities 175,080 116,432
Deferred tax liability 24,875 160
Operating lease liability, long-term 12,119 13,087
Seller's earn-out 55,100 0
Other long-term liabilities 240 97
Total liabilities 267,414 129,776
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.01 par value; 500,000,000 shares authorized; 65,396,253 and 64,186,549 shares issued at September 30, 2026 and December 31, 2025, respectively; 57,202,356 and 57,082,173 shares outstanding at September 30, 2026 and December 31, 2025, respectively 654 642
Additional paid-in capital 231,578 185,400
Retained earnings 342,956 228,014
Accumulated other comprehensive gain (loss) (1,050) 486
Treasury stock, 8,193,897 shares at cost as of September 30, 2026, and 7,104,376 shares at cost as of December 31, 2025. (145,410) (83,000)
Total stockholders’ equity 428,728 331,542
Total liabilities and stockholders’ equity $ 696,142 $ 461,318